Evidence map›Paper›PMID 40644622›Full record

ArticleInorganic chemistry2025

Organometallic Half-Sandwich Complexes of 1,10-Phenanthroline Derivatives with Improved Solubility, Albumin-Binding, and Nanoformulation Potential Targeting Drug Resistance in Cancer.

Egon F Várkonyi, Szilárd Tóth, Tamás Pivarcsik, Orsolya Dömötör, Ottó Berkesi, Nóra V May, Gergely Szakács, Edit Csapó, Éva A Enyedy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inorganic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Egon F VárkonyiDepartment of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
Szilárd TóthDrug Resistance Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.ORCID 0000-0002-0168-3531
Tamás PivarcsikDepartment of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
Orsolya DömötörDepartment of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.
Ottó BerkesiDepartment of Physical Chemistry and Materials Science, Interdisciplinary Excellence Centre, University of Szeged, Rerrich B. Sqr. 1, H-6720 Szeged, Hungary.
Nóra V MayCentre for Structural Science, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
Gergely SzakácsDrug Resistance Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, H-1117 Budapest, Hungary.
Edit CsapóMTA-SZTE Lendület "Momentum" Noble Metal Nanostructures Research Group, University of Szeged, Rerrich B. Sqr. 1, H-6720 Szeged, Hungary.
Éva A EnyedyDepartment of Molecular and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7-8, H-6720 Szeged, Hungary.ORCID 0000-0002-8058-8128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of Rh(III)(η

Indexed as

Antineoplastic AgentsCoordination ComplexesDrug Resistance, NeoplasmPhenanthrolinesSerum Albumin, HumanCell Line, TumorCell ProliferationDrug Resistance, MultipleDrug Screening Assays, AntitumorHumansMolecular StructureNanoparticlesRhodiumRutheniumSolubility1,10-phenanthrolineAntineoplastic AgentsCoordination ComplexesPhenanthrolinesRhodiumRutheniumSerum Albumin, Human

Identifiers

PMID40644622
PMCPMC12308784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.